Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA3
This opportunity focuses on Task Area 3 of the RAPIID program, which aims to bridge the gap between laboratory proof-of-concept and real-world clinical use for shelf-stable blood products. The goal is to deliver a complete, deployable, and authorized system for use in austere, pre-hospital settings by both military and civilian personnel. The program will fund studies to demonstrate safety and efficacy, ensure manufacturing scalability of blood analog components, and develop associated fielding technologies. No specific timelines, budget amounts, or location for performance of services are mentioned in the description.